Evommune EVMN
NYSE EVMN
$8.64 +0.80 (+10.14%)
As of: Nov 11, 2026 · 3:59 PM EST

Evommune (EVMN) Non-Current Assets (2024 - 2026)

Updated

Evommune (EVMN) recorded Non-Current Assets of $97.7 million in Q2 2026, down 8.3% from the prior quarter.

Analysis

Evommune (EVMN) Non-Current Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, Evommune reported Non-Current Assets of $71.47 million.

  • Across earlier years, Non-Current Assets came in at $2.07 million in FY2024.
  • Quarterly Non-Current Assets has ranged from $2.07 million in Q4 2024 to $106.6 million in Q1 2026 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $106.6 million (Q1 2026), $71.47 million (Q4 2025) and $2.6 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 82.81 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 141.07 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 110.20 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 75.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 88.47 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 61.69 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 34.86 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 159.99 Bn
10 Evommune 285.17 Mn -352.34 Mn - 97.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 97.70 Mn
Mar 31, 2026 106.60 Mn
Dec 31, 2025 71.47 Mn
Sep 30, 2025 2.60 Mn
Dec 31, 2024 2.07 Mn
API Access

Evommune Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=EVMN&period=max&api_key=YOUR_API_KEY